Results 61 to 70 of about 21,819 (222)
Identification of novel linear megaplasmids carrying a ß-lactamase gene in neurotoxigenic Clostridium butyricum type E strains. [PDF]
PLoS ONE, 2011 Since the first isolation of type E botulinum toxin-producing Clostridium butyricum from two infant botulism cases in Italy in 1984, this peculiar microorganism has been implicated in different forms of botulism worldwide.
Giovanna Franciosa +4 more
doaj +1 more source
PURIFICATION AND MOLECULAR WEIGHT DETERMINATION OF CLOSTRIDIUM BOTULINUM TYPE E TOXIN [PDF]
Journal of Bacteriology, 1964 Gerwing, Julia (The University of British Columbia, Vancouver, British Columbia, Canada), Claude E. Dolman, M. E. Reichmann, and Hardial S. Bains . Purification and molecular weight determination of Clostridium botulinum type E toxin. J. Bacteriol.
J, GERWING +3 more
openaire +2 more sources
Movement Disorders Clinical Practice, EarlyView.Abstract Background Non‐motor symptoms, especially autonomic dysfunction, are major contributors to disability and decreased quality of life in Parkinson's disease (PD). Despite being common and having a wide range of clinical facets, exocrine gland dysfunction is still not well recognized and managed.
Renato P. Munhoz +2 more
wiley +1 more source
Botulinum toxin: a new differential diagnosis for a lytic bone lesion
Journal of Medical Case ReportsBackground Botulinum toxin, produced by the Gram-positive anaerobe Clostridium botulinum, is composed of seven antigenic subtypes (A, B, C, D, E, F, and G). Currently, only Botulinum toxin type A, commonly referred to as “Botox,” is approved for clinical
Yael Lefkovits, Lara Lipton
doaj +1 more source
Movement Disorders Clinical Practice, EarlyView.Abstract Background Hyperkinetic movement disorders, including dystonia, tremor, and myoclonus, are disabling conditions often managed with botulinum toxin type A (BoNT‐A). Real‐world evidence on treatment patterns remains limited. Objective This nationwide, population‐based study aimed to evaluate trends in BoNT‐A use in France between 2015 and 2023 ...
Marion Simonetta‐Moreau +3 more
wiley +1 more source
Immunogenicity evaluation of rBoNT/E nanovaccine after mucosal administration [PDF]
Iranian Journal of Basic Medical Sciences, 2019 Objective(s): The Botulism syndrome is caused by types A to G of botulinum neurotoxins. The binding domains of these neurotoxins are immunogenic and considered as appropriate candidate vaccines.
MohamadJavad Bagheripour +3 more
doaj +1 more source
Majallah-i ̒Ilmī-i Shīlāt-i Īrān, 1999 In this study experiments were conducted to evaluate Clostridium botulinum type E in fresh and smoked Cyprinus carpio (60 samples) Rutilus frisii kutum (60 samples) and Hypophthalmichthys molitrix (60 samples). One hundred and eighty samples of fish were
R. Safari; I. Khandaghi
doaj
"Isolation of Clostridum botiulinum (Types A, B, E) in Sediments from Coastal Areas in the North of Iran" [PDF]
Iranian Journal of Public Health, 2003 Iranian J Publ Health, Vol. 32, No. 3, pp.37-40, 2003 Isolation of Clostridum botiulinum (Types A, B, E) in Sediments from Coastal Areas in the North of Iran *HR Tavakoli 1,V Razavilar 2 1Dept.
HR Tavakoli, V Razavilar
doaj +2 more sources
Movement Disorders Clinical Practice, EarlyView.Abstract Background Functional movement disorder (FMD), a subtype of functional neurological disorder, is a complex neuropsychiatric syndrome characterized by inconsistent and incongruent motor symptoms. Despite its relatively high prevalence, FMD remains associated with delayed diagnosis, significant disability, and limited evidence to guide ...
Andrea Soumbasis +6 more
wiley +1 more source
Revista Brasileira de Cirurgia Plástica, 2011 INTRODUÇÃO: A hiperidrose caracteriza-se por sudorese excessiva, isolada ou associada, da testa, das mãos, dos pés e das axilas. Atinge cerca de 1% da população.
Gilberto Marcos Dias dos Reis +2 more
doaj +1 more source